Recalling RAC's announcment of June 2022, highlighting abstracts published in Cancer Research, noteably Prof Chen's abstract that ...
"describes preclinical data demonstrating Zantrene’s ability to inhibit FTO and suppress pancreatic carcinogenesis via targeting cancer stem cell maintenance. Pancreatic cancer has few effective treatment options and patients need better treatments for this devastating disease"
Prof Chen on RAC's Scientific Advisory Board & Prof Van Hoff now on the Clinical Advsiory Board.
Since the both also work out of City of Hope, let's hope they catchup for a cofffee soon
https://www.raceoncology.com/wp-content/uploads/2022/06/Novel-preclinical-data-published-in-Cancer-Research-highlighting-Zantrenes-potential-in-colorectal-and-pancreatic-cancers.pdf
Recalling RAC's announcment of June 2022, highlighting abstracts...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.030(2.11%) |
Mkt cap ! $247.1M | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.45 | $1.40 | $163.8K | 115.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 31396 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |